Acute myocardial infarction in a young bodybuilder taking anabolic androgenic steroids: A case report and critical review of the literature

Eur J Prev Cardiol. 2016 Nov;23(16):1785-1796. doi: 10.1177/2047487316651341. Epub 2016 May 16.


We describe a case report of a 30-year-old bodybuilder suffering acute myocardial infarction (AMI). He had been taking stanozolol and testosterone for two months. The coronary angiogram showed high thrombotic burden in the left anterior descending artery without underlying atherosclerosis. Few case reports of AMI in athletes taking anabolic androgenic steroids (AASs) have been reported so far. AAS-related AMI is possibly underreported in the medical literature due to the desire of the affected individuals to hide AAS use. Physicians should always consider the possibility of AAS abuse in the context of a young athlete suffering AMI. AASs can predispose to AMI through the acceleration of coronary atherosclerosis. Additionally, thrombosis without underlying atherosclerosis or vasospasm is highly possible to cause AMI in AAS users. Complications after AMI may be more frequent in AAS users.

Keywords: Anabolic steroids; athletes; bodybuilding; myocardial infarction.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Anabolic Agents / adverse effects*
  • Athletes*
  • Doping in Sports*
  • Echocardiography
  • Electrocardiography / drug effects*
  • Humans
  • Male
  • ST Elevation Myocardial Infarction / chemically induced*
  • ST Elevation Myocardial Infarction / diagnosis
  • ST Elevation Myocardial Infarction / physiopathology
  • Somatotypes


  • Anabolic Agents